184 related articles for article (PubMed ID: 6843944)
1. Differential agglutination of P388 adriamycin-sensitive and P388 adriamycin-resistant leukemia cells.
Basrur VS; Chitnis MP; Menon RS
Oncology; 1983; 40(3):202-4. PubMed ID: 6843944
[TBL] [Abstract][Full Text] [Related]
2. Cell surface alterations in murine leukaemia P388 adriamycin-resistant cells: studies on lectin-induced agglutination and rearrangement of lectin receptors.
Basrur VS; Chitnis MP; Menon RS
Oncology; 1985; 42(5):328-31. PubMed ID: 4034147
[TBL] [Abstract][Full Text] [Related]
3. Resistance to adriamycin: relationship of cytotoxicity to drug uptake and DNA single- and double-strand breakage in cloned cell lines of adriamycin-sensitive and -resistant P388 leukemia.
Goldenberg GJ; Wang H; Blair GW
Cancer Res; 1986 Jun; 46(6):2978-83. PubMed ID: 3698020
[TBL] [Abstract][Full Text] [Related]
4. Enhancement of sensitivity to adriamycin in resistant P388 leukemia by the calmodulin inhibitor trifluoperazine.
Ganapathi R; Grabowski D
Cancer Res; 1983 Aug; 43(8):3696-9. PubMed ID: 6861140
[TBL] [Abstract][Full Text] [Related]
5. [In vitro evaluation of the chemosensitivity of an experimental murine leukemia rendered resistant in vivo to adriamycin].
Lepri E; Menconi E; Barzi AM
Boll Soc Ital Biol Sper; 1984 Jul; 60(7):1369-75. PubMed ID: 6477749
[TBL] [Abstract][Full Text] [Related]
6. Potentiation of adriamycin cytotoxicity in P388 murine leukemia sensitive and resistant to adriamycin by use of lonidamine and hyperthermia.
Chitnis M; Adwankar M
Tumori; 1986 Oct; 72(5):469-73. PubMed ID: 3798566
[TBL] [Abstract][Full Text] [Related]
7. Restoration of doxorubicin responsiveness in doxorubicin-resistant P388 murine leukaemia cells by dipyrone.
Chitnis MP; Kamath NS
Oncology; 1987; 44(1):47-50. PubMed ID: 3561929
[TBL] [Abstract][Full Text] [Related]
8. In vivo characteristics of resistance and cross-resistance of an adriamycin-resistant subline of P388 leukemia.
Johnson RK; Chitnis MP; Embrey WM; Gregory EB
Cancer Treat Rep; 1978 Oct; 62(10):1535-47. PubMed ID: 709555
[TBL] [Abstract][Full Text] [Related]
9. Comparative cytotoxicities of various morpholinyl anthracyclines.
Streeter DG; Taylor DL; Acton EM; Peters JH
Cancer Chemother Pharmacol; 1985; 14(2):160-4. PubMed ID: 3971481
[TBL] [Abstract][Full Text] [Related]
10. Restoration of drug sensitivity by nitroxazepine hydrochloride in P388 murine leukemia cells resistant to adriamycin.
Chitnis MP; Pradhan SG; Satyamoorthy K; Basrur VS
Cancer Drug Deliv; 1987; 4(1):1-9. PubMed ID: 3607719
[TBL] [Abstract][Full Text] [Related]
11. Plasma membrane lipid structural order in doxorubicin-sensitive and -resistant P388 cells.
Ramu A; Glaubiger D; Magrath IT; Joshi A
Cancer Res; 1983 Nov; 43(11):5533-7. PubMed ID: 6311408
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of quinidine effect on the antitumor activity of adriamycin and mitoxantrone in adriamycin-sensitive and -resistant P388 leukemia cells.
Parekh H; Chitnis M
Sel Cancer Ther; 1990; 6(2):93-102. PubMed ID: 2367755
[TBL] [Abstract][Full Text] [Related]
13. Differential effect of collaterally sensitive antimetabolites on P388 murine leukemia sensitive and resistant to adriamycin in vitro.
Satyamoorthy K; Deshpande SS; Chitnis MP
Neoplasma; 1989; 36(6):673-83. PubMed ID: 2515459
[TBL] [Abstract][Full Text] [Related]
14. Intracellular adriamycin levels and cytotoxicity in adriamycin-sensitive and adriamycin-resistant P388 mouse leukemia cells.
Ganapathi R; Reiter W; Krishan A
J Natl Cancer Inst; 1982 Jun; 68(6):1027-32. PubMed ID: 6953267
[TBL] [Abstract][Full Text] [Related]
15. Mechanism of acquired resistance to methotrexate in P388 murine leukemia cells and in their doxorubicin-resistant subline.
Ramu N; Ramu A; Cole DE; Balis FM; Poplack DG; Pollard HB
Isr J Med Sci; 1988; 24(9-10):477-82. PubMed ID: 2974448
[TBL] [Abstract][Full Text] [Related]
16. In vivo response of mitoxantrone and doxorubicin with dipyrone in parental and doxorubicin-resistant P388 leukemia.
Kamath NS; Chitnis MP
Oncology; 1990; 47(2):166-9. PubMed ID: 2314829
[TBL] [Abstract][Full Text] [Related]
17. Enhancement of vincristine- and adriamycin-induced cytotoxicity by verapamil in P388 leukemia and its sublines resistant to vincristine and adriamycin.
Tsuruo T; Iida H; Yamashiro M; Tsukagoshi S; Sakurai Y
Biochem Pharmacol; 1982 Oct; 31(19):3138-40. PubMed ID: 7150340
[TBL] [Abstract][Full Text] [Related]
18. Reversal of acquired resistance to doxorubicin in P388 murine leukemia cells by perhexiline maleate.
Ramu A; Fuks Z; Gatt S; Glaubiger D
Cancer Res; 1984 Jan; 44(1):144-8. PubMed ID: 6690032
[TBL] [Abstract][Full Text] [Related]
19. Murine splenocyte migration inhibition assay I. Detection of differential responses to murine leukemia P388 and its adriamycin-resistant subline P388/ADR.
Nori M; Gothoskar BP
Neoplasma; 1983; 30(3):287-93. PubMed ID: 6223231
[TBL] [Abstract][Full Text] [Related]
20. Relationship between the structure of analogues of amsacrine and their degree of cross-resistance to adriamycin-resistant P388 leukaemia cells.
Baguley BC; Finlay GJ
Eur J Cancer Clin Oncol; 1988 Feb; 24(2):205-10. PubMed ID: 3356208
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
